AndreaBozzo/ceres-open-data-index huggingface dataset:
2020 General Payment Data

All general (non-research, non-ownership related) payments from the 2020 program year [January 1 – December 31, 2020]<p><strong>NOTE: </strong>This is a very large file and, depending on your network characteristics and software, may take a long time to download or fail to download. Additionally, the number of rows in the file may be larger than the maximum rows your version of <a href="https://support.microsoft.com/en-us/office/excel-specifications-and-limits-1672b34d-7043-467e-8e27-269d656771c3">Microsoft Excel</a> supports. If you can't download the file, we recommend engaging your IT support staff. If you are able to download the file but are unable to open it in MS Excel or get a message that the data has been truncated, we recommend trying alternative programs such as MS Access, Universal Viewer, Editpad or any other software your organization has available for large datasets.</p>
Compound 526594: Phenol, 2,2'-methylenebis[4-methyl-, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethyl-[4-methyl-2-[(5-methyl-2-trimethylsilyloxyphenyl)methyl]phenoxy]silane. Molecular Formula: C21H32O2Si2. Molecular Weight: 372.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Effects of Welding Fume Exposure on Human Placental Cells

As more women join the skilled-trade workforce, the effects of workplace exposures on pregnancy need to be explored. This study aimed to identify the effects of mild-steel (MS) and stainless-steel (SS) welding fume exposures on first-trimester placental trophoblast cells, using the HTR-8/SVneo cell line. MS is primarily composed of Iron (Fe) and Manganese (Mn), while SS also contains chromium (Cr) and nickel (Ni). We found that all three welding fumes had significant effects on cellular viability, and also caused increases in free radical production, while negatively affecting their invasive capabilities. MS was the only sample to cause an increase in production of the pro-inflammatory cytokines IL-6 and IL-8. Our results show that welding fume exposure is in fact cytotoxic to trophoblasts, and understanding how these occupational exposures could impact maternal and fetal health is necessary. Identifying how the varying combinations of heavy metals and other materials present in MS and SS welding fumes, along
CDC Best Practices for Comprehensive Tobacco Control Programs - 2014

2014. Centers for Disease Control and Prevention (CDC). Best Practices for Comprehensive Tobacco Control Programs. Funding. CDC's Best Practices for Comprehensive Tobacco Control Programs is an evidence-based guide to help states plan and establish effective tobacco control programs to prevent and reduce tobacco use.  These data update Best Practices for Comprehensive Tobacco Control Programs—2007.  Data are reported at total and per capita funding levels. Data include recommended and minimum total funding levels for state programs, in addition to funding breakdowns by intervention areas such as: State and Community Interventions, Mass-Reach Health Communication Interventions, Cessation Interventions, Surveillance and Evaluation, and Infrastructure, Administration, and Management.
Program Instruction (PI-99-07)

This Program Instruction (PI) provides instruction to States on the June 30, 1999 Submission of: (1) the Child and Family Services Plan Final Report required for title IV-B of the Social Security Act (the Act); (2) the Fiscal Year 2000–2004 Child and Family Services Plan; (3) the CFS-101, Annual Budget Request and Annual Summary of Child and Family Services; (4) the Child Abuse and Neglect State Plan; and (5) the application for the Independent Living program (optional).

Metadata-only record linking to the original dataset. Open original dataset below.
Sodium chloride, sodium lactate, potassium chloride, and calcium chloride

Lactated Ringer's is an intravenous solution containing electrolytes such as sodium chloride, sodium lactate, potassium chloride, and calcium chloride. It's used to replace fluids and electrolytes in the body, typically administered through injection for medical purposes. Manufactured by B. Braun Medical Inc., it's available in various container sizes. This information was generated using AI and is provided for informational and research purposes only.
2014 CMHS Uniform Reporting System (URS) Table for Mississippi

2014 Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for Mississippi. The URS state reporting system is collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 529633: Dimethyl[(1-propyldodecyl)oxy]vinylsilane

Chemical compound data from PubChem database. IUPAC Name: 2-butan-2-yl-1,3-oxathiolane. Molecular Formula: C7H14OS. Molecular Weight: 146.25. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
COVID-19 State Profile Report - Michigan

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Compound 526716: Tetraethylene glycol, decyl ether, acetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-(2-decoxyethoxy)ethoxy]ethoxy]ethyl acetate. Molecular Formula: C20H40O6. Molecular Weight: 376.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Youth in Transition Database - Outcomes Survey

States report information from two reporting populations: (1) The Served Population which is information on all youth receiving at least one independent living services paid or provided by the Chafee Program agency, and (2) Youth completing the NYTD Survey.  States  survey youth regarding six outcomes: financial self-sufficiency, experience with homelessness, educational attainment, positive connections with adults, high-risk behaviors, and access to health insurance. States collect outcomes information by conducting a survey of youth in foster care on or around their 17th birthday, also referred to as the baseline population. States will track these youth as they age and conduct a new outcome survey on or around the youth's 19th birthday; and again on or around the youth's 21st birthday, also referred to as the follow-up population. States will collect outcomes information on these older youth at ages 19 or 21 regardless of their foster care status or whether they are still receiving independent living services from the State. Depending on the size of the State's foster care youth population, some States may conduct a random sample of the baseline population of the 17-year-olds that participate in the outcomes survey so that they can follow a smaller group of youth as they age. All States will collect and report outcome information on a new baseline population cohort every three years.

<b>Units of Response: </b>Current and former youth in foster care

<b>Type of Data: </b>Survey

<b>Tribal Data: </b>No

<b>Periodicity: </b>Annual

<b>Demographic Indicators: </b>Ethnicity;Race;Sex

<b>SORN: </b>Not Applicable

<b>Data Use Agreement: </b>https://www.ndacan.acf.hhs.gov/datasets/request-dataset.cfm

<b>Data Use Agreement Location: </b>https://www.ndacan.acf.hhs.gov/datasets/order_forms/termsofuseagreement.pdf

<b>Granularity: </b>Individual

<b>Spatial: </b>United States

<b>Geocoding: </b>State
Compound 528900: 5-Ethyl-5-cyclohepta-1,3-dienyl-hexahydropyrimidin-2,4,6-trione

Chemical compound data from PubChem database. IUPAC Name: 5-cyclohepta-1,3-dien-1-yl-5-ethyl-1,3-diazinane-2,4,6-trione. Molecular Formula: C13H16N2O3. Molecular Weight: 248.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
4.20 Facilities with Opioid Treatment Programs (OTPs) and clients receiving medication-assisted opioid therapy at OTPs and other facilities, by facility operation and primary focus of facility: March 31, 2011.  Number and percent distribution

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facilities with Opioid Treatment Programs (OTPs) and clients receiving medication-assisted opioid therapy at OTPs and other facilities, by facility operation and primary focus of facility in March 3, 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Comparison Between 2019-2020 NSDUH State Prevalence Estimates

State estimates for these years are no longer available due to methodological concerns with combining 2019 and 2020 data. We apologize for any inconvenience or confusion this may causeBecause of the COVID-19 pandemic, most respondents answered the survey via the web in Quarter 4 of 2020, even though all responses in Quarter 1 were from in-person interviews. It is known that people may respond to the survey differently while taking it online, thus introducing what is called a mode effect.When the state estimates were released, it was assumed that the mode effect was similar for different groups of people. However, later analyses have shown that this assumption should not be made. Because of these analyses, along with concerns about the rapid societal changes in 2020, it was determined that averages across the two years could be misleading.For more detail on this decision, see the 2019-2020state data page.
Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions

Background:
          We have developed and tested a method for printing protein microarrays and using these microarrays in a comparative fluorescence assay to measure the abundance of many specific proteins in complex solutions. A robotic device was used to print hundreds of specific antibody or antigen solutions in an array on the surface of derivatized microscope slides. Two complex protein samples, one serving as a standard for comparative quantitation, the other representing an experimental sample in which the protein quantities were to be measured, were labeled by covalent attachment of spectrally resolvable fluorescent dyes.
        
        
          Results:
          Specific antibody-antigen interactions localized specific components of the complex mixtures to defined cognate spots in the array, where the relative intensity of the fluorescent signal representing the experimental sample and the reference standard provided a measure of each protein's abundance in the experimental sample. To test the specificity, sensitivity and accuracy of this assay, we analyzed the performance of 115 antibody/antigen pairs. 50% of the arrayed antigens and 20% of the arrayed antibodies provided specific and accurate measurements of their cognate ligands at or below concentrations of 0.34 μg/ml and 1.6 μg/ml, respectively. Some of the antibody/antigen pairs allowed detection of the cognate ligands at absolute concentrations below 1 ng/ml, and partial concentrations of 1 part in 106, sensitivities sufficient for measurement of many clinically important proteins in patient blood samples.
        
        
          Conclusions:
          These results suggest that protein microarrays can provide a practical means to characterize patterns of variation in hundreds of thousands of different proteins in clinical or research applications.
Compound 527980: Propanoic acid, 2-methyl-, 2-chloro-1-(chloromethyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 1,3-dichloropropan-2-yl 2-methylpropanoate. Molecular Formula: C7H12Cl2O2. Molecular Weight: 199.07. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528680: Nicotinamide, TMS

Chemical compound data from PubChem database. IUPAC Name: trimethylsilyl N-trimethylsilylpyridine-3-carboximidate. Molecular Formula: C12H22N2OSi2. Molecular Weight: 266.49. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529518: Fisetin, TMS

Chemical compound data from PubChem database. IUPAC Name: 2-[3,4-bis(trimethylsilyloxy)phenyl]-3,7-bis(trimethylsilyloxy)chromen-4-one. Molecular Formula: C27H42O6Si4. Molecular Weight: 575.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525163: Heptapropylene glycol, diacetate

Chemical compound data from PubChem database. IUPAC Name: 2-[2-[2-[2-[2-[2-(2-acetyloxypropoxy)propoxy]propoxy]propoxy]propoxy]propoxy]propyl acetate. Molecular Formula: C25H48O10. Molecular Weight: 508.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
San Francisco Flood Health Vulnerability

The San Francisco Department of Public Health Flood Health Vulnerability Index is a composite index that measures the spatial distribution and relative vulnerability of San Francisco communities to the health impacts of flood inundation and extreme storms. The index is constructed using socioeconomic and demographic, exposure, health, and housing indicators and is intended to serve as a planning tool for health and climate adaptation. Steps for calculating the index can be found in in the "An Assessment of San Francisco’s Vulnerability to Flooding & Extreme Storms" located at https://sfclimatehealth.org/wp-content/uploads/2018/12/FloodVulnerabilityReport_v5.pdf.pdf

Data dictionary can be found in the attachments section of the metadata.
Raleigh-Durham-Cary, NC

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Raleigh-Durham-Cary, NC metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Raleigh-Durham-Cary metro area, North Carolina, and the U.S. overall.
The linkage between β1 integrin and the actin cytoskeleton is differentially regulated by tyrosine and serine/threonine phosphorylation of β1 integrin in normal and cancerous human breast cells

Background
          Structural requirements for the β1 integrin functions in cell adhesion, spreading and signaling have been well documented mainly for fibroblasts. In this study, we examined the reason for the reduced surface expression of β1 integrin in human breast cancer MCF-7 cells compared to normal human breast epithelial (HBE) cells, both of which adhered to collagen type IV.
        
        
          Results
          The β1 integrin immunoprecipitates from either HBE or MCF-7 cells involved α-actinin while actin coprecipitated with β1 integrin from HBE cells but not from MCF-7 cells. Immunoblotting using the anti-phosphotyrosine (PY) antibody indicated the phosphorylation of β1 integrin at least at tyrosine in both cells. Dephosphorylation of β1 integrin from HBE cells by protein tyrosine phosphatase (PTP), but not by protein serine/threonine phosphatase (PP), caused dissociation of actin from β1 integrin, although dephosphorylation of it from MCF-7 cells by either PTP or PP caused association of the two proteins. In MCF-7 cells β1 integrin coprecipitated doublet of proteins having the Ca2+/calmodulin-dependent protein kinase (CaMK) II activity that was susceptible to KN-62, a specific inhibitor of CaMKII.
        
        
          Conclusion
          The results suggest that β1 integrin is tyrosine phosphorylated and links with actin via α-actinin in HBE cells but prevented from linking with actin in MCF-7 cells by phosphorylation at both tyrosine and serine/threonine of β1 integrin which forms a complex with α-actinin and CaMKII. Thus the linkage formation of β1 integrin with actin may be differentially regulated by its tyrosine and serine/threonine phosphorylation in normal HBE cells and breast cancer MCF-7 cells.
Compound 526993: Hexanal octane-1,3-diol acetal

Chemical compound data from PubChem database. IUPAC Name: 2,4-dipentyl-1,3-dioxane. Molecular Formula: C14H28O2. Molecular Weight: 228.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Title IV-E Programs Expenditure and Caseload Data 2021

The Children’s Bureau posts an annual FY summary of Form CB-496 expenditures and caseloads as reported by each title IV-E agency. These data tables include the combination of current-quarter and prior-quarter adjustment expenditures and current-quarter caseload data as delineated in quarterly Form CB-496 submissions for FY 2021.

Metadata-only record linking to the original dataset. Open original dataset below.
Patent AT-E401378-T1: [Translated] PRESERVATIVE-FREE COATING AGENTS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE

A description is given of coating compositions comprising at least one strongly basic agent to set a pH of at least 10, at least one selected vinyl ester copolymer, if desired, pigment and/or filler, and, if desired, further additives customary per se. The coating compositions can be stored without use of additional preservatives and can be used to coat substrates of all kinds.
Detection of fast light-activated H

Background
          Proteorhodopsin (pR) is a light-activated proton pump homologous to bacteriorhodopsin and recently discovered in oceanic γ-proteobacteria. One perplexing difference between these two proteins is the absence in pR of homologues of bR residues Glu-194 and Glu-204. These two residues, along with Arg-82, have been implicated in light-activated fast H+ release to the extracellular medium in bR. It is therefore uncertain that pR carries out its physiological activity using a mechanism that is completely homologous to that of bR.
        
        
          Results
          A pR purification procedure is described that utilizes Phenylsepharose™ and hydroxylapatite columns and yields 85% (w/w) purity. Through SDS-PAGE of the pure protein, the molecular weight of E.-coli-produced pR was determined to be 36,000, approximately 9,000 more than the 27,000 predicted by the DNA sequence. Post-translational modification of one or more of the cysteine residues accounts for 5 kDa of the weight difference as measured on a cys-less pR mutant. At pH 9.5 and in the presence of octylglucoside and diheptanoylphosphotidylcholine, flash photolysis results in fast H+ release and a 400-nm absorbing (M-like) photoproduct. Both of these occur with a similar rise time (4–10 μs) as reported for monomeric bR in detergent.
        
        
          Conclusions
          The presence of fast H+ release in pR indicates that either different groups are responsible for fast H+ release in pR and bR (i.e. that the H+ release group is not highly conserved); or, that the H+ release group is conserved and is therefore likely Arg-94 itself in pR (and Arg-82 in bR, correspondingly).
Compound 529492: 3-Amino-5,6-dimethyltriazolo[4,3-a]pyrazine

Chemical compound data from PubChem database. IUPAC Name: 5,6-dimethyl-[1,2,4]triazolo[4,3-a]pyrazin-3-amine. Molecular Formula: C7H9N5. Molecular Weight: 163.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Minneapolis: Drug-Related Emergency Department Visits, 2004-2011 - All Alcohol

Excel file with estimates, rates, relative standard errors, trends and confidence intervals, covering 2004-2011 for emergency department visits involving alcohol in the Miami metropolitan area.  For adults aged 21 and older, the alcohol was found in combination with other drugs. For patients under the age of 21, the visit may involve alcohol alone or in combination with other drugs.File includes data for over 500 drugs, including illicit drugs, prescription and over-the-counter medications, dietary supplements, inhalants and alcohol.  Includes total visits, gender, age group, race/ethnicity, outcome of visit, drug combinations, number of drugs involved in visit, drug frequency, and drugs confirmed by toxicology.Additional detail is provided for illicit drugs, psychotherapeutic drugs, central nervous system (CNS) drugs, respiratory drugs and cardiovascular drugs.